These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6957528)
21. [Circulating anticoagulant directed against factor XI in a patient with biliary lithiasis]. Durán Suárez JR Rev Clin Esp; 1983 Mar; 168(6):383-6. PubMed ID: 6878764 [No Abstract] [Full Text] [Related]
22. Activation of factor IX by factor XIa--a spectrophotometric assay for factor IX in human plasma. Tans G; Janssen-Claessen T; van Dieijen G; Hemker HC; Rosing J Thromb Haemost; 1982 Oct; 48(2):127-32. PubMed ID: 6983739 [TBL] [Abstract][Full Text] [Related]
23. The lupus inhibitor: a study of its heterogeneity. Coots MC; Miller MA; Glueck HI Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826 [TBL] [Abstract][Full Text] [Related]
24. A circulating lupus-like coagulation inhibitor induced by chlorpromazine. Tollefson G; Rodysill K; Cusulos M J Clin Psychopharmacol; 1984 Feb; 4(1):49-51. PubMed ID: 6420448 [TBL] [Abstract][Full Text] [Related]
25. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency. Lim S; Zuha R; Burt T; Chacko J; Scott R; Mainwaring CJ Blood Coagul Fibrinolysis; 2006 Nov; 17(8):667-71. PubMed ID: 17102654 [TBL] [Abstract][Full Text] [Related]
26. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma. Orstavik KH Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818 [TBL] [Abstract][Full Text] [Related]
30. [Thrombocytic complications in a patient with an inhibitor against the contact factor]. Papaian LP; Litmanovich KIu Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):56-9. PubMed ID: 1273067 [No Abstract] [Full Text] [Related]
31. Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report. Denis A; Baudeau C; Verdy E; Couderc R; Rondeau E; Sraer JD Nouv Rev Fr Hematol (1978); 1995; 37(2):165-9. PubMed ID: 7644356 [TBL] [Abstract][Full Text] [Related]
32. Total knee replacement in a patient with lupus anticoagulant. Bhagia UT; Corpe RS; Steflik D J South Orthop Assoc; 1997; 6(3):231-4. PubMed ID: 9322205 [TBL] [Abstract][Full Text] [Related]
33. Inhibitors of plasma thromboplastin antecedent (factor XI): studies on mechanism of inhibition. Goldsmith GH; Silverman P J Lab Clin Med; 1985 Sep; 106(3):279-85. PubMed ID: 3875671 [TBL] [Abstract][Full Text] [Related]
34. The role of factor IX in tissue thromboplastin induced coagulation. van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540 [TBL] [Abstract][Full Text] [Related]
35. Studies on a circulating anticoagulant in systemic lupus erythematosus: evidence for inhibition of the function of activated plasma thromboplastin antecedent (factor XIa). Krieger H; Leddy JP; Breckenridge RT Blood; 1975 Aug; 46(2):189-97. PubMed ID: 237589 [TBL] [Abstract][Full Text] [Related]
36. [Prolonged activated partial thromboplastin time (aPTT): not always indicative of increased risk of bleeding]. van der Pas AJ; Leebeek FW; Perry DJ; Castel A; van Esser JW Ned Tijdschr Geneeskd; 2009; 153():B42. PubMed ID: 19785809 [TBL] [Abstract][Full Text] [Related]
38. Acquired factor IX inhibitor in a patient with adenocarcinoma of the colon. Collins HW; Gonzalez MF Acta Haematol; 1984; 71(1):49-52. PubMed ID: 6419526 [TBL] [Abstract][Full Text] [Related]
39. First diagnosis of factor XI deficiency in a patient with subarachnoid haemorrhage. Vasileiadis I; El-Ali M; Nanas S; Kolias S; Zacharatos P; Christopoulou-Cokkinou V; Kotanidou A Blood Coagul Fibrinolysis; 2009 Jun; 20(4):309-13. PubMed ID: 19367158 [TBL] [Abstract][Full Text] [Related]